Viyash Scientific Allots 1.2 Lakh Equity Shares Under ESOP Plan
Viyash Scientific allotted 1,20,000 equity shares under its ESOP 2020 plan at an exercise price of ₹86 per share. This increases the company's paid-up capital to ₹87,37,01,620, comprising 43,68,50,810 equity shares.
The allotment of equity shares under an ESOP plan is a routine event and typically has a minimal impact on the company's overall market capitalization or share price, as it's a pre-planned compensation mechanism.
The announcement is a routine ESOP allotment, which is a standard corporate action and does not significantly impact the company's financial performance or market position in a positive or negative way.
Viyash Scientific Limited (formerly Sequent Scientific Limited) announced the allotment of 1,20,000 Equity Shares of ₹2 each, fully paid, to eligible employees. The allotment was approved by the Nomination and Remuneration Committee via resolution passed by circulation on February 26, 2026. The exercise price for these shares is ₹86 per equity share, under the SeQuent ESOP 2020 plan.
The newly allotted equity shares will rank pari passu in all respects with the existing equity shares of the company. Following this allotment, the company's issued and paid-up equity share capital has increased from ₹87,34,61,620 (comprising 43,67,30,810 Equity Shares of ₹2 each) to ₹87,37,01,620 (comprising 43,68,50,810 Equity Shares of ₹2 each).
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under other company updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.